ATM c.497A>C ;(p.E166A)

Variant ID: 11-108114680-A-C

NM_000051.3(ATM):c.497A>C;(p.E166A)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Inhibition of SARS-CoV-2 Viral Channel Activity Using FDA-Approved Channel Modulators Independent of Variants.

Biomolecules
Yu, Han-Gang HG; Sizemore, Gina G; Martinez, Ivan I; Perrotta, Peter P
Publication Date: 2022-11-11

Variant appearance in text: ATD: E166A
PubMed Link: 36421688
Variant Present in the following documents:
  • biomolecules-12-01673.pdf
View BVdb publication page



Distant and new mutations in CTX-M-1 beta-lactamase affect cefotaxime hydrolysis.

Antimicrobial Agents And Chemotherapy
Pérez-Llarena, Francisco José FJ; Kerff, Frédéric F; Abián, Olga O; Mallo, Susana S; Fernández, María Carmen MC; Galleni, Moreno M; Sancho, Javier J; Bou, Germán G
Publication Date: 2011-09

Variant appearance in text: ATM: E166A
PubMed Link: 21730121
Variant Present in the following documents:
  • Main text
View BVdb publication page